Shuxuening Injection

1. It has anti-myocardial ischemia effect. Ginkgo biloba total flavonoids can significantly reduce the total amplitude of abnormal ST segment elevation and the number of pathological Q waves in the electrocardiogram, inhibit the release of creatine phosphokinase in myocardial tissue, and reduce the scope of myocardial infarction. 2. It has anti-cerebral ischemia effect. Ginkgo biloba extract can promote the rapid recovery of ischemic cortical electroencephalogram, reduce the volume of cerebral infarction in rats with middle cerebral artery ischemia-reperfusion model caused by common carotid artery insertion, and significantly reduce the number of apoptotic cells. 3. It has anti-atherosclerosis effect. Ginkgo biloba extract can significantly reduce the percentage of aortic atherosclerotic plaque area, reduce plasma malondialdehyde (MDA) content and nitric oxide (NO) level. 4. It has anti-arrhythmic effect. Ginkgo biloba extract can reduce the large amount of cerebral ischemia induced by jugular vein injection of aconitine and barium chloride.

This product is a sterilized aqueous solution made by extracting ginkgo leaves.

This product is a yellow clear liquid.

Intramuscular injection: 10 ml at a time, 1-2 times a day. Intravenous drip: 20 ml per day, diluted with 5% glucose injection to 250 ml or 500 ml, or as directed by a doctor.

Allergic reactions are rare.

Use with caution in pregnant women and patients with heart failure.

Precautions during pregnancy and lactation: Use with caution in pregnant women.

There is no information on the interaction of this product with other drugs.

Sealed and protected from light.

5ml per bottle

36 months.

Shineway Pharmaceutical Group Ltd.

• Founded in:

  2003-12-30

• Address:

  No. 168, Shiluan Street, Luancheng District, Shijiazhuang City, Hebei Province

• Tax NO.:

  91130000757518418T

• Registered Funds:

  $136 million

• Website:

  Log in to view

• Email:

  Log in to view